.svg){kind=icon}
Cannabis tinctures and oral drops are often described as sublingual products.
The term “sublingual” means:
under the tongue.
The idea is straightforward: cannabinoids placed beneath the tongue may cross the thin tissues of the mouth and enter circulation without first traveling entirely through the stomach and liver.
In practice, however, sublingual cannabis pharmacology is more complicated.
Some cannabinoids may be absorbed through the oral mucosa.
Some may remain in the mouth.
And some may ultimately be swallowed.
That means many tincture experiences represent a combination of oromucosal absorption and conventional oral absorption.
For Florida medical cannabis patients, understanding this distinction can help explain why tinctures may have different onset times from both inhaled cannabis and traditional edibles.
What Is the Oral Mucosa?
The oral mucosa is the tissue lining the inside of the mouth.
It includes areas such as:
- Under the tongue
- Inside the cheeks
- Gums
- Other oral surfaces
These tissues contain blood vessels located relatively close to the surface.
Certain medications can cross these membranes and enter circulation directly.
This type of administration is called transmucosal delivery.
When medication is specifically placed under the tongue, it is usually described as:
sublingual administration.
When placed against the cheek, it may be called:
buccal administration.
The broader term oromucosal can include both.
Why Use the Sublingual Route?
One theoretical advantage of sublingual administration is that some of the drug may enter circulation without first undergoing gastrointestinal absorption.
That can potentially reduce the amount exposed to immediate first-pass liver metabolism.
With swallowed THC, the liver converts some THC into:
11-hydroxy-THC
before much of the dose reaches systemic circulation.
If THC crosses directly through the oral mucosa, some of that early first-pass metabolism may be bypassed.
In theory, this can produce:
- Faster absorption than conventional oral products
- Less gastrointestinal involvement
- Different metabolite exposure
- Potentially more predictable dosing in certain formulations
However, the actual result depends heavily on the product.
Sublingual Does Not Mean Everything Is Absorbed Under the Tongue
This is one of the most important patient-education points.
Placing cannabis oil under the tongue does not guarantee that the entire dose immediately enters the bloodstream.
Cannabinoid absorption depends on several factors, including:
- Formulation
- Carrier oil or solvent
- Cannabinoid concentration
- Contact time
- Saliva production
- Oral tissue characteristics
- How much product is swallowed
Once the remaining liquid is swallowed, that portion enters the gastrointestinal tract.
It then behaves more like a conventional oral cannabis dose.
Why Cannabinoids Can Be Difficult to Absorb
THC and CBD are highly lipophilic.
That means they dissolve readily in fats but poorly in water.
Human tissues contain both lipid and water-based environments.
For a cannabinoid to move efficiently through the oral mucosa, it must leave its formulation, pass through mucus, cross cellular membranes, and enter nearby blood vessels.
That process is not always efficient.
This is why pharmaceutical researchers continue developing specialized cannabinoid formulations designed to improve mucosal absorption.
Formulation Can Change Absorption
Two tinctures containing the same amount of THC may not behave identically.
Formulation variables may include:
- MCT oil
- Alcohol
- Emulsifiers
- Surfactants
- Nanoparticles
- Mucoadhesive materials
- Dissolving films
- Tablets
- Sprays
Researchers are studying these technologies because improving contact with the oral mucosa may improve cannabinoid absorption.
This is also why results from one standardized oromucosal medication should not automatically be applied to every dispensary tincture.
What Does the Research on Oromucosal Cannabis Show?
One of the most extensively studied oromucosal cannabinoid formulations is nabiximols, a standardized THC/CBD spray.
Research shows that cannabinoids from oromucosal products can enter systemic circulation.
However, pharmacokinetic studies also show evidence that some of the dose is swallowed.
Researchers have observed 11-hydroxy-THC after oromucosal administration.
That metabolite is strongly associated with liver metabolism.
Its presence demonstrates that at least part of the THC entered the gastrointestinal and hepatic pathway.
How Fast Does Sublingual Cannabis Work?
There is no single guaranteed onset time.
Research involving standardized oromucosal formulations commonly places onset somewhere around:
15 to 60 minutes
but individual studies and products vary.
That is generally faster than many conventional swallowed edibles but slower than inhalation.
A useful simplified comparison is:
Inhaled cannabis: usually fastest
Oromucosal/sublingual: intermediate
Traditional swallowed cannabis: generally slower
These are approximate categories rather than fixed rules.
Why Peak Effects May Come Later Than Onset
Onset means:
When do I begin noticing an effect?
Peak means:
When might the effect be strongest?
Those are different.
A tincture may begin producing noticeable effects relatively early while cannabinoid concentrations continue rising afterward.
Human oromucosal pharmacokinetic studies have reported peak blood concentrations occurring hours after administration in some formulations.
Patients should therefore avoid assuming that the first noticeable effect represents the maximum effect.
Does Holding a Tincture Under the Tongue Longer Improve Absorption?
Possibly, but the relationship is not precise enough to support a universal rule such as:
“Hold it for exactly 60 seconds and 100% will absorb.”
Longer contact may provide more opportunity for mucosal absorption.
But actual absorption still depends on the formulation and the patient.
Some product will often be swallowed regardless.
Patients should follow the instructions provided for the specific product.
Sublingual vs Oral Cannabis
The difference can be summarized conceptually.
Primarily Sublingual or Oromucosal
Cannabinoids may enter circulation through oral tissue.
This may partially bypass immediate first-pass liver metabolism.
Swallowed Oral Cannabis
Cannabinoids travel through the digestive tract and then the liver.
This generally results in greater first-pass metabolism and more formation of metabolites such as 11-hydroxy-THC.
Real-World Tincture Use
Often involves some combination of both pathways.
This mixed pathway helps explain why tincture effects can vary.
Sublingual vs Inhaled Cannabis
Inhalation generally produces much faster cannabinoid absorption than tinctures.
THC can enter circulation through the lungs within minutes.
Sublingual or oromucosal administration is slower.
However, liquid products can provide a more clearly measured amount than descriptions such as:
“one puff.”
A dropper with labeled milligrams per milliliter can make dose tracking easier, provided the product is used according to its instructions.
Milligrams Still Matter
The route does not replace the dose.
For example:
2.5 mg THC sublingually
and
20 mg THC sublingually
use the same administration route but provide very different cannabinoid quantities.
Patients should review:
- Milligrams of THC
- Milligrams of CBD
- Volume administered
- Cannabinoid ratio
- Route
- Timing
All of these affect the overall dosing picture.
Medication Interactions Still Matter
Bypassing part of first-pass metabolism does not mean cannabis avoids the liver entirely.
Once cannabinoids circulate through the body, they can eventually be metabolized by liver enzymes.
THC and CBD can interact with enzyme systems involved in metabolism of other medications.
Patients taking multiple prescriptions should discuss cannabis use with their qualified physician or pharmacist.
This is especially important with medications involving:
- Sedation
- Seizure management
- Blood thinning
- Cardiovascular conditions
- Psychiatric treatment
- Liver metabolism
Florida Product Route Matters
Florida medical cannabis products are assigned approved routes of administration.
A product that physically looks suitable for sublingual use should not automatically be assumed to be authorized for that route.
Patients should follow:
- The product label
- OMMU route designation
- Their physician's order
- Manufacturer instructions
The formulation and approved route should take priority over assumptions based on packaging.
Green Dragon Florida Product Examples
The following products illustrate differences between liquid and swallowed cannabis formulations.
They are educational examples rather than individualized medical recommendations.
Le Remedie Drops THC Tincture — Lake City
Le Remedie Drops THC Tincture contains 100 mg THC total in a 1-fluid-ounce bottle.
The current product page lists ten 10 mg dose units.
Importantly, Green Dragon currently identifies this specific Florida product for the ingestion route.
Although tinctures as a general dosage form may sometimes be administered sublingually, patients should follow the route and instructions listed for the actual Florida product.
Le Remedie Drops Low-THC Tincture — Tampa
The current Green Dragon Tampa tincture menu lists Le Remedie Drops Low-THC Tincture at approximately 3,120 mg CBD in a 1-ounce bottle, with no measurable THC shown on the menu listing.
This illustrates why patients should look at actual cannabinoid milligrams and formulation rather than assuming all tinctures contain similar THC ratios.
Patients should also confirm the approved route and dosing instructions for the current product before use.
Green Dragon Wild Strawberry Sativa Chews — Ocala
Green Dragon Wild Strawberry Sativa Chews contain 100 mg THC total.
These are useful as a comparison because a chew is intended to be swallowed.
Unlike a formulation designed for oral-mucosal contact, swallowed THC primarily enters through gastrointestinal absorption and undergoes first-pass liver metabolism.
Product availability, route designation, and formulation details may change by Green Dragon Florida location.
The Green Dragon Takeaway
Sublingual cannabis is best understood as oral-mucosal drug delivery, not simply as “an edible that works faster.”
Cannabinoids placed under the tongue may cross oral tissues and enter circulation.
But absorption is rarely complete.
Some of the dose is often swallowed, meaning the final pharmacokinetic profile may combine:
mucosal absorption
and
gastrointestinal absorption.
That is why tinctures can fall pharmacokinetically between inhaled cannabis and traditional oral edibles.
For medical cannabis patients, the most useful approach is to consider:
the cannabinoid dose, the formulation, the approved route, and the expected timing together.